DaVita Inc. (DVA)
NYSE: DVA · Real-Time Price · USD
178.64
-2.03 (-1.12%)
Aug 7, 2026, 10:25 AM EDT - Market open
DaVita Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 14,010 | 13,643 | 12,816 | 12,140 | 11,610 | 11,619 |
Revenue Growth | 6.45% | 6.46% | 5.56% | 4.57% | -0.08% | 0.59% |
Gross Profit Gross Profit Growth | 4,533 | 4,400 | 4,217 | 3,820 | 3,400 | 3,646 |
Operating Income Operating Income Growth | 2,128 | 2,044 | 2,090 | 1,603 | 1,339 | 1,797 |
Net Income Net Income Growth | 847.48 | 746.8 | 936.34 | 691.54 | 560.4 | 978.45 |
Earnings Per Share EPS Growth | 12.22 | 9.84 | 10.73 | 7.42 | 5.85 | 8.90 |
EPS Growth | 20.16% | -8.29% | 44.61% | 26.84% | -34.27% | 39.28% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
US Dialysis US Dialysis Growth | 11,946 | 11,732 | 11,319 | 10,849 | 10,513 | 10,576 |
Other - Ancillary Dialysis Other - Ancillary Dialysis Growth | 2,064 | 1,911 | 1,497 | 1,291 | 1,097 | 1,043 |
Revenue (Total) Revenue (Total) Growth | 14,010 | 13,643 | 12,816 | 12,140 | 11,610 | 11,619 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 688.88 | 700.74 | 846 | 391.67 | 321.78 | 484.21 |
Total Debt Total Debt Growth | 13,406 | 12,874 | 12,067 | 11,116 | 11,822 | 11,975 |
Net Cash (Debt) Net Cash Growth | -12,718 | -12,174 | -11,221 | -10,725 | -11,501 | -11,491 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -181.68 | -160.42 | -128.57 | -115.09 | -120.01 | -104.51 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,193 | 1,887 | 2,022 | 2,059 | 1,565 | 1,931 |
Capital Expenditures CapEx Growth | -583.35 | -575.86 | -555.44 | -567.99 | -603.43 | -641.47 |
Free Cash Flow Free Cash Flow Growth | 1,610 | 1,311 | 1,467 | 1,491 | 961.14 | 1,289 |
Free Cash Flow Growth | 24.96% | -10.63% | -1.64% | 55.13% | -25.46% | -1.16% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 32.36% | 32.25% | 32.91% | 31.47% | 29.29% | 31.38% |
Operating Margin | 15.19% | 14.98% | 16.31% | 13.20% | 11.53% | 15.47% |
Pretax Margin | 10.48% | 9.87% | 11.94% | 9.70% | 8.32% | 13.07% |
Profit Margin | 8.31% | 7.72% | 9.76% | 7.88% | 6.62% | 10.43% |
FCF Margin | 11.49% | 9.61% | 11.44% | 12.28% | 8.28% | 11.10% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.38 | 11.55 | 13.94 | 14.12 | 12.76 | 12.78 |
Forward PE | 11.30 | 9.23 | 13.74 | 12.48 | 12.69 | 14.02 |
P/FCF Ratio | 7.06 | 5.94 | 8.21 | 6.24 | 7.02 | 8.58 |
PS Ratio | 0.81 | 0.57 | 0.94 | 0.77 | 0.58 | 0.95 |